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Development of the Assessment of Burden of COPD tool:
an integrated tool to measure the burden of COPD
Annerika HM Slok1, Johannes CCM in ’t Veen2, Niels H Chavannes3, Thys van der Molen4,5, Maureen PMH Rutten-van Mölken6,
Huib AM Kerstjens7, Philippe L Salomé8, Sebastiaan Holverda9, PN Richard Dekhuijzen10, Denise Schuiten10, Guus M Asijee1,11
and Onno CP van Schayck1
In deciding on the treatment plan for patients with chronic obstructive pulmonary disease (COPD), the burden of COPD as
experienced by patients should be the core focus. It is therefore important for daily practice to develop a tool that can both assess
the burden of COPD and facilitate communication with patients in clinical practice. This paper describes the development of an
integrated tool to assess the burden of COPD in daily practice. A definition of the burden of COPD was formulated by a Dutch
expert team. Interviews showed that patients and health-care providers agreed on this definition. We found no existing instruments
that fully measured burden of disease according to this definition. However, the Clinical COPD Questionnaire meets most
requirements, and was therefore used and adapted. The adapted questionnaire is called the Assessment of Burden of COPD (ABC)
scale. In addition, the ABC tool was developed, of which the ABC scale is the core part. The ABC tool is a computer program with an
algorithm that visualises outcomes and provides treatment advice. The next step in the development of the tool is to test the
validity and effectiveness of both the ABC scale and tool in daily practice.
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Chronic obstructive pulmonary disease (COPD) imposes a great
burden on patients and is a major cause of morbidity with a
significant impact on the wider economy.1
Airway obstruction used to play an important role in assessing
disease severity and in treating COPD. Nowadays, the focus of
COPD assessment shifts from merely airway obstruction towards
patient-reported outcomes. Hence, the assessment addresses
complaints, limitations in daily and social life, the progression of
disease, and quality of life from the patients’ perspective.2
Research has shown that multidimensional indicators, such as
the Body Mass Index, Airflow Obstruction, Dyspnoea, and Exercise
Capacity Index3 and quality of life,4 are better predictors of
morbidity, mortality and health-care utilisation than the forced
expiratory volume in 1 s (FEV1) alone. Agusti and MacNee
5
describe the necessity of a more personalised approach.
The development of our novel Assessment of Burden of COPD
(ABC) tool intends to contribute to this approach. It allows
quantification and visualisation of the burden of COPD, thereby
facilitating the integrated approach crucial for assessment and
individualised treatment of COPD.
A Dutch expert team was instituted by the Dutch Lung Alliance
(in Dutch: Long Alliantie Nederland, LAN) to develop a tool to
measure the burden of COPD. Several steps were taken to develop
this tool. The first step was to define the burden of COPD. The
following definition was formulated:
Burden of disease is the physical, emotional, psychological
and/or social experiences of a patient with COPD. These
experiences influence the patient´s ability to cope with the
consequences of COPD and its treatment.
The second step was to validate this definition with the
experiences of patients and health-care providers. Therefore, three
focus group interviews with a total of 17 patients, 21 face-to-face
interviews with different health-care professionals and three home
visits to severely ill, homebound COPD patients were conducted.
The interviews confirmed that our definition was in line with the
experiences of patients and health-care providers.
The third step was to define the conditions that a burden of
COPD instrument should meet. The Dutch expert group for-
mulated nine conditions (Box 1).
The fourth step was to perform a literature review to search for
questionnaires, instruments or indexes that measure the burden
of COPD. The literature review revealed that the currently available
instruments do not fully measure the burden of disease according
to our definition and they do not meet all the formulated
requirements (Figure 1). However, the Clinical COPD Question-
naire (CCQ) met most requirements and was therefore considered
to be closest to reflecting the concept of burden of COPD. The
CCQ has shown good validity, reliability and responsiveness at
group and individual levels.6,7
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The fifth step was to develop the ABC scale using the CCQ as a
basis. This scale is the core part of the ABC tool. The CCQ was
adapted by adding questions for the lacking domains of
emotions8 and fatigue.9 Three items were added to measure
emotional experiences. These items are based on the distress
screener of the four-dimensional symptom questionnaire,8 which
measures listlessness, worry and feeling tense. The questions from
the distress screener were revised to match the format of the CCQ
questions. Furthermore, a question was added about fatigue,
based on a study by Van Hooff et al.9 This item was also
formulated in the same way as the questions on the CCQ. The
14 items together form the ABC scale (Table 1). The combination
of the ABC scale with objective items—such as a patient’s
smoking status and body mass index—creates a measure of the
integrated health status of an individual COPD patient. We
developed a computer program to visualise the integrated health
status of a COPD patient, represented as a balloon for each item of
the ABC tool (Figure 2). The combination of the ABC scale, the
additional indicators and the visualisation of the scores together
forms the ABC tool. A high, green balloon indicates that a patient
scores well on a particular item. These green balloons can be used
to compliment the patient (e.g., not smoking) and to encourage
the patient to continue that behaviour. A low, red balloon
indicates that the patient experiences problems on that item.
Every score in between is indicated with an orange balloon. The
red and dark-orange balloons can be the starting point of
discussing the options for improvement with the patient during
consultations. Hence, it forms the basis for shared decision making
Box 1 Requirements for measuring burden of COPD
The instrument should meet the following requirements:
1. include indicators that provide insight into impairments,
disabilities, complaints and quality of life resulting from
COPD;
2. measure the physical, emotional, psychological and social
experiences of patients with COPD;
3. based on patient input;
4. easy for both patient and caregiver to manage and should
therefore:
a take no more than a few minutes to complete;
b have an easy score calculation;
c have the potential to be self-administered by patients.
5. responsive to change in patients;
6. able to measure differences between patients;
7. have a visual display including:
a subscores of the different domains and a total score;
b minimum and maximum length variants.
8. able to guide treatment;
9. possibility to connect with generic Quality of Life
instruments such as the SF36 (i.e., capable of obtaining and
calculating QALYs (Quality Adjusted Life Years; societal
perspective)).
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Figure 1. An overview of assessment tools in relation to requirements for a burden of disease instrument.
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(SDM). Furthermore, an algorithm was developed to link the
scores on the integrated health status with treatment advices.
These were based on (inter)national treatment guidelines. This
advice can guide the patient and care provider towards an
integrated and personalised therapy. The ABC tool is consistent
with SDM principles.10 The patient is considered to have a certain
Table 1. The Assessment of Burden of COPD scale
Never Hardly
ever
A few
times
Several
times
Many
times
A great
many times
Almost
all the time
On average, during the past week, how often did you feel:
1. Short of breath at rest? □ □ □ □ □ □ □
2. Short of breath doing physical activities? □ □ □ □ □ □ □
3. Concerned about getting a cold or your breathing
getting worse?
□ □ □ □ □ □ □
4. Depressed (down) because of your breathing
problems?
□ □ □ □ □ □ □
In general, during the past week, how much of the time:
5. Did you cough? □ □ □ □ □ □ □
6. Did you produce phlegm? □ □ □ □ □ □ □
Not limited
at all
Very slightly
limited
Slightly
limited
Moderately
limited
Very
limited
Extremely
limited
Totally limited/ or
unable to do
On average, during the past week, how limited were you in these activities because of your breathing problems:
7. Strenuous physical activities (such as climbing
stairs, hurrying, doing sports)?
□ □ □ □ □ □ □
8. Moderate physical activities (such as walking,
house work, carrying things)?
□ □ □ □ □ □ □
9. Daily activities at home (such as dressing, washing
yourself )?
□ □ □ □ □ □ □
10. Social activities (such as talking, being with
children, visiting friends/relatives)?
□ □ □ □ □ □ □
Never Hardly ever A few
times
Several
times
Many
times
A great
many times
Almost all
the time
How often in the past week did you suffer from:
11. Worry? □ □ □ □ □ □ □
12. Listlessness? □ □ □ □ □ □ □
13. A tense feeling? □ □ □ □ □ □ □
14. Fatigue? □ □ □ □ □ □ □
Smoking Exacerbations Dyspnea BMI Lungfunction Physical
activity
Complaints Physical
health
Mental
health
Fatigue Emotions
Figure 2. Visualisation of the dimensions influencing integrated health status (Assessment of Burden of COPD tool), changed after treatment.
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level of responsibility in the treatment that lies within his or her
possibilities. The patient and health-care provider together can
select one balloon on which to elaborate further (SDM choice
phase). Clicking on a balloon gives access to treatment options
(SDM option phase). The patient and health-care provider can
then decide on the treatment goal by selecting an option and
placing it in the patient’s treatment plan (SDM decision phase).
This goal can then be adjusted further to the individual patient’s
needs and preferences. SDM and a personal goal are important in
motivating patients to feel responsible for their own treatment
and well-being. When treatment advice is followed and the
treatment is effective, the consequence is that the balloon for that
particular item (e.g. body mass index) will move to a higher (more
green) position or will not further decrease. As shown in Figure 2,
patients see both the current balloons and the balloons of the
previous consultation, which are made gray. The tool can
therefore be used during each consultation to monitor a patient’s
integrated health status over time. The next step in the
development of the tool is to test its validity, its responsiveness
and its effectiveness. Therefore it is important to perform a
randomised clinical trial that investigates whether the quality of
care and quality of life can be improved by using the ABC tool.
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